{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:58:02Z","timestamp":1791313082140,"version":"4.3.1"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-024-01929-4","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T11:25:34Z","timestamp":1713266734000},"page":"1391-1395","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Uremic toxins and the brain in chronic kidney disease"],"prefix":"10.1093","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1627-0235","authenticated-orcid":false,"given":"Maurizio","family":"Bossola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Picconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,4,16]]},"reference":[{"issue":"6","key":"1929_CR1","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1053\/j.ajkd.2019.05.017","volume":"74","author":"DA Drew","year":"2019","unstructured":"Drew DA, Weiner DE, Sarnak MJ (2019) Cognitive impairment in CKD: pathophysiology, management, and prevention. Am J Kidney Dis 74(6):782\u2013790. https:\/\/doi.org\/10.1053\/j.ajkd.2019.05.017","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"1929_CR2","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1212\/01.wnl.0000225182.15532.40","volume":"67","author":"AM Murray","year":"2006","unstructured":"Murray AM, Tupper DE, Knopman DS, Gilbertson DT, Pederson SL, Li S, Smith GE, Hochhalter AK, Collins AJ, Kane RL (2006) Cognitive impairment in hemodialysis patients is common. Neurology 67(2):216\u2013223. https:\/\/doi.org\/10.1212\/01.wnl.0000225182.15532.40","journal-title":"Neurology"},{"issue":"2","key":"1929_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1053\/j.ackd.2008.01.010","volume":"15","author":"AM Murray","year":"2008","unstructured":"Murray AM (2008) Cognitive impairment in the aging dialysis and chronic kidney disease populations: an occult burden. Adv Chronic Kidney Dis 15(2):123\u2013132. https:\/\/doi.org\/10.1053\/j.ackd.2008.01.010","journal-title":"Adv Chronic Kidney Dis"},{"issue":"3","key":"1929_CR4","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000000976","volume":"6","author":"MS van Sandwijk","year":"2020","unstructured":"van Sandwijk MS, Ten Berge IJM, Caan MWA, D\u00fcring M, van Gool WA, Majoie CBLM, Mutsaerts HMM, Schmand BA, Schrantee A, de Sonneville LMJ, Bemelman FJ (2020) Cognitive improvement after kidney transplantation is associated with structural and functional changes on MRI. Transplant Direct 6(3):e531. https:\/\/doi.org\/10.1097\/TXD.0000000000000976","journal-title":"Transplant Direct"},{"key":"1929_CR5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0197-0186(95)00041-6","volume":"27","author":"PP De Deyn","year":"1995","unstructured":"De Deyn PP et al (1995) Guanidino compound levels in brain regions of non-dialyzed uremic patients. Neurochem Int 27:227\u2013237. https:\/\/doi.org\/10.1016\/0197-0186(95)00041-6","journal-title":"Neurochem Int"},{"issue":"4","key":"1929_CR6","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1525-139X.2009.00577.x","volume":"22","author":"PP De Deyn","year":"2009","unstructured":"De Deyn PP, Vanholder R, Eloot S, Glorieux G (2009) Guanidino compounds as uremic (neuro)toxins. Semin Dial 22(4):340\u2013345. https:\/\/doi.org\/10.1111\/j.1525-139X.2009.00577.x","journal-title":"Semin Dial"},{"issue":"7","key":"1929_CR7","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1681\/ASN.2019070728","volume":"31","author":"M Bobot","year":"2020","unstructured":"Bobot M, Thomas L, Moyon A, Fernandez S, McKay N, Balasse L, Garrigue P, Brige P, Chopinet S, Poitevin S, C\u00e9rini C, Brunet P, Dignat-George F, Burtey S, Guillet B, Hache G (2020) Uremic toxic blood-brain barrier disruption mediated by AhR activation leads to cognitive impairment during experimental renal dysfunction. J Am Soc Nephrol 31(7):1509\u20131521","journal-title":"J Am Soc Nephrol"},{"key":"1929_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.lfs.2016.07.020","volume":"161","author":"MK Mazumder","year":"2016","unstructured":"Mazumder MK, Giri A, Kumar S, Borah A (2016) A highly reproducible mice model of chronic kidney disease: evidences of behavioural abnormalities and blood-brain barrier disruption. Life Sci 161:27\u201336. https:\/\/doi.org\/10.1016\/j.lfs.2016.07.020","journal-title":"Life Sci"},{"issue":"7","key":"1929_CR9","first-page":"2137","volume":"10","author":"W Jing","year":"2018","unstructured":"Jing W, Jabbari B, Vaziri ND (2018) Uremia induces upregulation of cerebral tissue oxidative\/inflammatory cascade, down-regulation of Nrf2 pathway and disruption of blood brain barrier. Am J Transl Res 10(7):2137\u20132147","journal-title":"Am J Transl Res"},{"issue":"1","key":"1929_CR10","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1038\/s41598-022-08387-7","volume":"12","author":"L Hernandez","year":"2022","unstructured":"Hernandez L, Ward LJ, Arefin S, Ebert T, Laucyte-Cibulskiene A; GOING-FWD Collaborators; Heimb\u00fcrger O, Barany P, Wennberg L, Stenvinkel P, Kublickiene K (2022) Blood-brain barrier and gut barrier dysfunction in chronic kidney disease with a focus on circulating biomarkers and tight junction proteins. Sci Rep 12(1):4414. https:\/\/doi.org\/10.1038\/s41598-022-08387-7","journal-title":"Sci Rep"},{"issue":"2","key":"1929_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/toxins13020142","volume":"13","author":"YJ Lim","year":"2021","unstructured":"Lim YJ, Sidor NA, Tonial NC, Che A, Urquhart BL (2021) Uremic toxins in the progression of chronic kidney disease and cardiovascular disease: mechanisms and therapeutic targets. Toxins (Basel) 13(2):142. https:\/\/doi.org\/10.3390\/toxins13020142","journal-title":"Toxins (Basel)"},{"issue":"7","key":"1929_CR12","doi-asserted-by":"publisher","first-page":"6628","DOI":"10.3390\/ijms2407662","volume":"24","author":"L Hernandez","year":"2023","unstructured":"Hernandez L, Ward LJ, Arefin S, Barany P, Wennberg L, S\u00f6derberg M, Bruno S, Cantaluppi V, Stenvinkel P, Kublickiene K (2023) Blood-brain barrier biomarkers before and after kidney transplantation. Int J Mol Sci 24(7):6628. https:\/\/doi.org\/10.3390\/ijms2407662","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1929_CR13","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41420-021-00685-9","volume":"7","author":"G Natale","year":"2021","unstructured":"Natale G, Calabrese V, Marino G, Campanelli F, Urciuolo F, de Iure A, Ghiglieri V, Calabresi P, Bossola M, Picconi B (2021) Effects of uremic toxins on hippocampal synaptic transmission: implication for neurodegeneration in chronic kidney disease. Cell Death Discov 7(1):295. https:\/\/doi.org\/10.1038\/s41420-021-00685-9","journal-title":"Cell Death Discov"},{"issue":"2","key":"1929_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/s0304-3940(99)00190-1","volume":"26","author":"R D\u2019Hooge","year":"1999","unstructured":"D\u2019Hooge R, De Deyn PP, Van de Vijver G, Antoons G, Raes A, Van Bogaert PP (1999) Uraemic guanidino compounds inhibit gamma-aminobutyric acid-evoked whole cell currents in mouse spinal cord neurones. Neurosci Lett 265(2):83\u201386. https:\/\/doi.org\/10.1016\/s0304-3940(99)00190-1","journal-title":"Neurosci Lett"},{"issue":"7","key":"1929_CR15","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3390\/brainsci12070905","volume":"12","author":"YH Yu","year":"2022","unstructured":"Yu YH, Kim SW, Im H, Oh SW, Cho NJ, Park S, Park DK, Kim DS, Gil HW (2022) Cognitive sequelae and hippocampal dysfunction in chronic kidney disease following 5\/6 nephrectomy. Brain Sci 12(7):905. https:\/\/doi.org\/10.3390\/brainsci12070905","journal-title":"Brain Sci"},{"issue":"1","key":"1929_CR16","doi-asserted-by":"publisher","first-page":"9483","DOI":"10.1038\/s41598-020-66421-y","volume":"10","author":"M Karbowska","year":"2020","unstructured":"Karbowska M, Hermanowicz JM, Tankiewicz-Kwedlo A, Kalaska B, Kaminski TW, Nosek K, Wisniewska RJ, Pawlak D (2020) Neurobehavioral effects of uremic toxin-indoxyl sulfate in the rat model. Sci Rep 10(1):9483. https:\/\/doi.org\/10.1038\/s41598-020-66421-y","journal-title":"Sci Rep"},{"issue":"2","key":"1929_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e06221","volume":"7","author":"K Watanabe","year":"2021","unstructured":"Watanabe K, Sato E, Mishima E, Watanabe M, Abe T, Takahashi N, Nakayama M (2021) Effect of uremic toxins on hippocampal cell damage: analysis in vitro and in rat model of chronic kidney disease. Heliyon 7(2):e06221. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e06221","journal-title":"Heliyon"},{"issue":"2","key":"1929_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/jcm8020191","volume":"8","author":"YT Lin","year":"2019","unstructured":"Lin YT, Wu PH, Tsai YC, Hsu YL, Wang HY, Kuo MC, Kuo PL, Hwang SJ (2019) Indoxyl sulfate induces apoptosis through oxidative stress and mitogen-activated protein kinase signaling pathway inhibition in human astrocytes. J Clin Med 8(2):191. https:\/\/doi.org\/10.3390\/jcm8020191","journal-title":"J Clin Med"},{"key":"1929_CR19","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.neuro.2016.01.006","volume":"53","author":"YC Yeh","year":"2016","unstructured":"Yeh YC, Huang MF, Liang SS, Hwang SJ, Tsai JC, Liu TL, Wu PH, Yang YH, Kuo KC, Kuo MC, Chen CS (2016) Indoxyl sulfate, not p-cresyl sulfate, is associated with cognitive impairment in early-stage chronic kidney disease. Neurotoxicology 53:148\u2013152. https:\/\/doi.org\/10.1016\/j.neuro.2016.01.006","journal-title":"Neurotoxicology"},{"key":"1929_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.neuro.2019.02.019","volume":"73","author":"YT Lin","year":"2019","unstructured":"Lin YT, Wu PH, Lee HH, Mubanga M, Chen CS, Kuo MC, Chiu YW, Kuo PL, Hwang SJ (2019) Indole-3 acetic acid increased risk of impaired cognitive function in patients receiving hemodialysis. Neurotoxicology 73:85\u201391. https:\/\/doi.org\/10.1016\/j.neuro.2019.02.019","journal-title":"Neurotoxicology"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-01929-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-024-01929-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-01929-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:53:47Z","timestamp":1777564427000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/37\/5\/1391\/8306720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,16]]},"references-count":20,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["1929"],"URL":"https:\/\/doi.org\/10.1007\/s40620-024-01929-4","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,16]]},"assertion":[{"value":"11 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent to participate"}}]}}